marijuanaBenzodiazepinesCocaineheroinpain killersfaqabout uscontact us
Study Name Who's Treated? Age Treatment components Duration Study Status
Outpatient Opiate Detox Study Heroin users or people who use prescription pain killers 18-60 Buprenorphine or oral naltrexone

Individual sessions of cognitive behavioral therapy
One week outpatient detox followed by 4 weeks of outpatient treatment. Participants have the option of receiving two additional Vivitrol injections upon completion of the initial 5 week trial. Active and recruiting participants
Outpatient Opiate Detox Study


The purpose of this research study is to examine the effectiveness of two methods of opioid detoxification: oral naltrexone and buprenorphine taper. Both forms of detoxification will be conducted over 8 days on an outpatient basis, and will be followed by induction onto long-acting injectable naltrexone (Vivitrol®) and individual therapy for five weeks. Vivitrol® blocks the effects of opiates and has no opiate-like effects, and is approved by the FDA for the treatment of opioid dependence.
Type of Treatment: This is an eight-week outpatient study that starts with an eight-day period of detoxification using either buprenorphine or naltrexone in addition to medications designed to reduce the discomfort of withdrawal. After detox an injection of Vivitrol® is given. Then, clinic visits will be required twice weekly for five weeks. These visits take between 30 and 60 minutes, and include questionnaires, vital signs, individual therapy, and psychiatric evaluations. After the study is finished, patients are able to continue meeting with staff for four weeks. This is to go over progress made during the trial and to find referrals for continued treatment if requested.

For more information about Vivitrol® please visit:


The Substance Treatment and Research Service of Columbia University (STARS) provides free and confidential treatment of substance abuse in the context of a research treatment clinical trial.

Cutting edge approaches to treating addiction to marijuana, benzodiazepines, cocaine, heroin or narcotic painkillers are available in a supportive and professional environment.
Study participation in all trials is FREE and transportation costs will be reimbursed. Call 212-923-3031 to schedule an appointment today.